Search

Your search keyword '"Cheng, Hui-Jun"' showing total 19 results
Start Over Author "Cheng, Hui-Jun"
19 results on '"Cheng, Hui-Jun"'

1. Accelerated Parallel Based Distance Calculations for Live-Cell Time-Lapse Images

Author

Cheng, Hui-Jun, Lin, Chun-Yuan, Mao, Chun-Chien, Barbosa, Simone Diniz Junqueira, Editorial Board Member, Filipe, Joaquim, Editorial Board Member, Ghosh, Ashish, Editorial Board Member, Kotenko, Igor, Editorial Board Member, Yuan, Junsong, Editorial Board Member, Zhou, Lizhu, Editorial Board Member, Chang, Chuan-Yu, editor, Lin, Chien-Chou, editor, and Lin, Horng-Horng, editor

Published
2019
Full Text
View/download PDF

2. Computing Image Intersection and Union Regions for Drosophila Neurons Based on Multi-core CPUs

Author

Guo, Ming-Yan, Cheng, Hui-Jun, Lin, Chun-Yuan, Lin, Yen-Jen, Chiang, Ann-Shyn, Barbosa, Simone Diniz Junqueira, Editorial Board Member, Filipe, Joaquim, Editorial Board Member, Ghosh, Ashish, Editorial Board Member, Kotenko, Igor, Editorial Board Member, Zhou, Lizhu, Editorial Board Member, Esposito, Christian, editor, Hong, Jiman, editor, and Choo, Kim-Kwang Raymond, editor

Published
2019
Full Text
View/download PDF

16. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy

Author

Xiao, Yan, Ren, Ying-Kun, Cheng, Hui-Jun, Wang, Li, and Luo, Su-Xia

Subjects
Adult, Chi-Square Distribution, Time Factors, Uterine Cervical Neoplasms, Chemoradiotherapy, Kaplan-Meier Estimate, Middle Aged, Risk Assessment, Disease-Free Survival, Treatment Outcome, Predictive Value of Tests, Risk Factors, Lymphatic Metastasis, Multivariate Analysis, Biomarkers, Tumor, Health Status Indicators, Humans, Original Article, Female, Inflammation Mediators, Aged, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies
Abstract

Objectives: There is increasing evidence that the presence of an inflammation-based prognostic score (modified Glasgow prognostic score, mGPS) could predict survival in patients with advanced cancer. The aim of this study was to investigate the prognostic value of mGPS in patients with cervical cancer. Methods: We included 238 consecutive patients with cervical cancer in our study. The albumin and serum C-reactive protein (CRP) were measured before initiation of treatment. The relationships between the mGPS and other clinical parameters including body mass index (BMI), white blood cell count, lymphocyte, platelet, hemoglobin, total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) were analyzed. Overall survival (OS) and progression-free survival (PFS) were calculated. Significant prognostic factors were identified using univariate and multivariate analyses. Results: The 5-year OS rate for all patients was 52.1% and 5-year PFS rate was 42.3%. Patients with mGPS of 0, 1 and 2 were 138, 71, 29, respectively. Higher mGPS was related to more advanced disease, including higher FIGO stage, lymph node metastases and lower lymphocyte counts, BMI and hemoglobin level. Performance status (PS), FIGO stage, lymph nodal status and mGPS were independent prognostic indicators for OS and PFS in the multivariate analysis. Conclusions: Higher mGPS is associated with advanced cervical cancer. The mGPS is an easily measurable biomarker which can be used in combination with conventional FIGO stage to predict survival in patients with cervical cancer undergoing chemoradiotherapy.

Published
2015

17. Consumers' trust of Professional Soccer League Games in China.

Author

Cheng Hui-jun

Abstract

The article discusses the conditions of consumer's trust on the Professional Soccer League Games in China. The author used the trust theory in presenting the present conditions of consumer's trust. The reasons of low trust were analyzed by using research methods and surveys. Several constructive criteria on the Professional Soccer League Games in China were presented which were taken from the experiences of the English Premier League.

Published
2007

18. Advances on microRNA in regulating mammalian skeletal muscle development.

Author

Li XY, Fu LL, Cheng HJ, and Zhao SH

Subjects
Animals, Cell Differentiation, Cell Proliferation, Energy Metabolism, Humans, MicroRNAs physiology, Muscle Development, Muscle, Skeletal growth & development
Abstract

MicroRNA (miRNA) is a class of short non-coding RNA, which is about 22 bp in length. In mammals, miRNA exerts its funtion through binding with the 3°-UTR region of target genes and inhibiting their translation. Skeletal muscle development is a complex event, including: proliferation, migration and differentiation of skeletal muscle stem cells; proliferation, differentiation and fusion of myocytes; as well as hypertrophy, energy metabolism and conversion of muscle fiber types. The miRNA plays important roles in all processes of skeletal muscle development through targeting the key factors of different stages. Herein we summarize the miRNA related to muscle development, providing a better understanding of the skeletal muscle development.

Published
2017
Full Text
View/download PDF

19. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.

Author

Xiao Y, Ren YK, Cheng HJ, Wang L, and Luo SX

Subjects
Adult, Aged, Biomarkers, Tumor blood, Chi-Square Distribution, Disease-Free Survival, Female, Humans, Inflammation Mediators blood, Kaplan-Meier Estimate, Lymphatic Metastasis, Middle Aged, Multivariate Analysis, Neoplasm Staging, Predictive Value of Tests, Proportional Hazards Models, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Uterine Cervical Neoplasms blood, Uterine Cervical Neoplasms diagnosis, Uterine Cervical Neoplasms mortality, Chemoradiotherapy adverse effects, Chemoradiotherapy mortality, Health Status Indicators, Uterine Cervical Neoplasms therapy
Abstract

Objectives: There is increasing evidence that the presence of an inflammation-based prognostic score (modified Glasgow prognostic score, mGPS) could predict survival in patients with advanced cancer. The aim of this study was to investigate the prognostic value of mGPS in patients with cervical cancer., Methods: We included 238 consecutive patients with cervical cancer in our study. The albumin and serum C-reactive protein (CRP) were measured before initiation of treatment. The relationships between the mGPS and other clinical parameters including body mass index (BMI), white blood cell count, lymphocyte, platelet, hemoglobin, total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) were analyzed. Overall survival (OS) and progression-free survival (PFS) were calculated. Significant prognostic factors were identified using univariate and multivariate analyses., Results: The 5-year OS rate for all patients was 52.1% and 5-year PFS rate was 42.3%. Patients with mGPS of 0, 1 and 2 were 138, 71, 29, respectively. Higher mGPS was related to more advanced disease, including higher FIGO stage, lymph node metastases and lower lymphocyte counts, BMI and hemoglobin level. Performance status (PS), FIGO stage, lymph nodal status and mGPS were independent prognostic indicators for OS and PFS in the multivariate analysis., Conclusions: Higher mGPS is associated with advanced cervical cancer. The mGPS is an easily measurable biomarker which can be used in combination with conventional FIGO stage to predict survival in patients with cervical cancer undergoing chemoradiotherapy.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results